Podcasts about Prostate cancer

What Causes Cancer? The Truth Most Doctors Don't Talk AboutIn this episode of Intellectual Medicine, Dr. Stephen Petteruti explores the relationship between cancer, metabolism, sugar, insulin, body fat, and prostate cancer progression. He discusses the Warburg theory, which suggests that cancer may begin with dysfunctional mitochondrial metabolism, and compares it with the later focus on genetic causes of cancer. While he argues that the idea of “starving cancer” by eliminating sugar is too simplistic, he also emphasizes that metabolic health plays a real role in cancer risk and progression.The episode focuses heavily on prostate cancer, which Dr. Petteruti describes as unique compared with other cancers. He argues that conventional approaches often overlook the environment in which cancer develops, including excess body fat, high insulin, elevated blood sugar, inflammation, and poor metabolic health. He also discusses tests such as fasting insulin, hemoglobin A1c, and continuous glucose monitoring, as well as the importance of nutritional and behavioral change. The episode closes with a warning against extreme diets, oversimplified supplement advice, and one-size-fits-all cancer theories.Timestamps:(00:00) What Causes Cancer?(01:02 )The Warburg Theory(02:14) Genetics vs. Metabolism(04:22) Why “Starving Cancer” Is Too Simplistic(05:42) Body Fat, Insulin, and Prostate Cancer(08:30) Tests That May Help Assess Metabolic Health(10:47) Food, Weight Loss, and Cancer Risk(13:42) The Anti-Cancer Lifestyle(15:04) Toxins, Viruses, and Parasites(16:15) NAD, Mitochondria, and Supplement Caution(17:33) Growth Hormone, IGF-1, and Cancer Risk(19:12) Why Extreme Dieting Is Not the AnswerEnjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.Book: Fight Cancer Like a Man: https://tinyurl.com/FightLikeAManBookDr. Steve's email newsletter: https://drstephenpetteruti.substack.com/subscribePodcast show notes : https://www.intellectualmedicine.com/podcast-notesMember exclusive content: https://tinyurl.com/DrPetterutiMemberLearn more: https://www.drstephenpetteruti.com/ Learn more: https://www.intellectualmedicine.com/ Connect with Dr. Petteruti on:⁠Instagram: ⁠https://www.instagram.com/dr.stephenpetteruti/⁠ Facebook: ⁠https://www.facebook.com/dr.stephenpetteruti⁠ Disclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.

Tanya Dorff joins Tom and Brian to discuss her ASCO 2026 data on a novel dual targeting ADC in prostate cancer. The broader scope of ADC development in prostate cancer is discussed with a focus on cytopenia toxicity and future direcctions.

Season 3 of Prostate Talk continues with a deep dive into one of the most important topics in prostate cancer care: precision.In this second episode, Maude Pavageau welcomes Dr. Eduard Baco to discuss the critical role of accurate image fusion in prostate biopsy.From improving targeting accuracy to helping reduce missed diagnoses and supporting more personalized treatment decisions, this conversation highlights how technology is reshaping the prostate cancer journey.

AUA Guidelines: Clinically Localized Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: James Eastham, MD, FACS To access the full guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/guidelines/clinically-localized-prostate-cancer

Prostate cancer treatment can bring lasting physical and emotional changes — and many men are caught off guard by how long recovery actually takes. Here is what to expect and how peer support helps. To learn more, visit https://prostaid.org/meetings/ Prostaid Calgary City: Calgary Address: 1600 90 Avenue Southwest Website: https://prostaid.org/

Learn about the Healing Power of Prolonged Fasting: HEREWhat if the prostate treatment your doctor recommended wasn't your only choice?Joel Pruttis came to Dr. Katie Deming with a rising PSA, a lesion seen on his prostate MRI, and a urologist telling him he probably had cancer. But something about it didn't sit right, so he paused, did his research, and made a choice many people in his position may never hear about.Dr. Katie and Joel talk through what it's like to face a scary diagnosis, feel pushed toward a system that doesn't quite feel right, and find the courage to try something different. Joel's story centers on prostate health, but the questions he wrestled with will feel familiar to anyone who has ever wondered if there's another way.Chapters:00:06:17 - Why the MRI Room Changed Everything00:07:09 - Two PSA Numbers, One Big Question00:09:17 - The Reason He Trusted Dr. Katie00:10:09 - The Part of Fasting That Scared Him Most00:11:45 - Why He Took the Leap Anyway00:13:09 - What 14 Days Without Food Actually Felt Like00:14:52 - The Subtle Shift That Told Him It Was Working00:16:13 - The Treatment Path He Almost Walked Into00:23:37 - The Health Changes He Didn't Expect00:29:30 - The Decision That Could Have Changed His Life00:34:40 - The Cost Comparison No One Talks About00:38:47 - The Healing Path Hidden in Plain SightIt's not only about Joel's lab results after a 14-day water fast, but everything else that shifted along the way, things he wasn't even looking for when he started.If you've ever felt stuck between fear and uncertainty, or wondered whether the standard path is really your only option, stay until the end. Joel shares exactly what he would say to anyone standing at that crossroads right now.Press play and learn what happened when one man decided to trust his body first.Join Dr. Katie's 3-Day Guided Fast, for expert support, daily live calls, and a community to fast alongside: Sign-Up Follow Dr. Katie Deming on InstagramWatch on YoutubeDISCLAIMER: The Born to Heal Podcast  is intended for informational purposes only and is not a substitute for seeking professional medical advice, diagnosis, or treatment. Individual medical histories are unique; therefore, this episode should not be used to diagnose, treat, cure, or prevent any disease without consulting your healthcare provider.A thought-provoking podcast explores cancer through the lens of holistic medicine and functional medicine, discussing causes of cancer, metabolic health, and unconventional approaches like water fasting, fasting and autophagy, and detox, while weighing fasting benefits against chemo side effects and radiation side effects, sharing stories of a cancer survivor navigating chemotherapy, natural medicine, holistic healing, and even spiritual healing on the path toward cancer remission and holistic health. 

Can you really treat prostate cancer effectively without knowing the genetics? In this episode of BackTable Urology, Dr. Evan Yu and Dr. Tanya Dorff join host Dr. Alan Tan to discuss why genetic testing is essential in personalized prostate cancer care. They discuss when and how to perform germline and somatic testing, address common barriers, and share best practices for counseling patients. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Pfizer. --- Timestamps 00:00 - Introduction02:18 - Who Gets Somatic Testing?06:43 - Patient Barriers to Testing09:00 - Genetic Testing Workflow12:28 - Treating BRCA2 Alterations24:18 - Monitoring Progression: ctDNA vs. PSA vs. Imaging29:32 - Treating mCRPC with ATM Mutations34:39 - CDK12 Classification 37:43 - Closing Takeaways --- More about this episode The doctors explore how BRCA2 and other DNA repair alterations can directly shape treatment decisions, focusing on the roles of PARP inhibitors and platinum therapy in advanced cases. The discussion highlights why both germline and somatic testing are critical for identifying actionable mutations and discuss the nuances of interpreting test results, including current limitations and emerging biomarkers. They also examine challenges such as insurance coverage, patient misconceptions, and workflow integration, as well as the movement toward truly personalized, biology-driven approaches in prostate cancer care. --- Resources Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial:https://pmc.ncbi.nlm.nih.gov/articles/PMC12705445/ Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study:https://www.annalsofoncology.org/article/S0923-7534(25)04936-1/fulltext Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer:https://www.nejm.org/doi/full/10.1056/NEJMoa1903307 ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patientshttps://www.sciencedirect.com/science/article/pii/S0302283825048766 First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer:https://www.nejm.org/doi/abs/10.1056/NEJMoa2502929 PROMISE Registry:https://www.prostatecancerpromise.org/ Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00683-X/abstract --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Steven Seyedin discusses radiation therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41558]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Steven Seyedin discusses radiation therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41558]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Steven Seyedin discusses radiation therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41558]

Recorded in Chicago, Dr. Aly-Khan Lalani and Dr. Chris Wallis unpack a massive slate of prostate cancer data, fresh from the 2026 ASCO Annual Meeting. The conversation spans the entire disease spectrum, beginning with a deep dive into the PROTEUS trial. Shifting to advanced disease, Dr. Lalani and Dr. Wallis discuss the TALAPRO-3 and the A-DREAM/Alliance A032101 trials. Concluding with a review of sequencing chemotherapy and radioligand therapy in the PLUDO trial, this episode provides an excellent overview of the prostate cancer landscape presented at ASCO 2026.This podcast has been made possible through unrestricted financial support by Johnson & Johnson, Pfizer, Tolmar, AbbVie, Astellas, Eisai, Ipsen, Merck, Bayer, TerSera.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.ca

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Spencer Behr discusses PSMA PET and functional imaging. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41557]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Jonathan Chou discusses targeted therapies. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41563]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Jonathan Chou discusses targeted therapies. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41563]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Spencer Behr discusses PSMA PET and functional imaging. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41557]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Spencer Behr discusses PSMA PET and functional imaging. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41557]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Jonathan Chou discusses targeted therapies. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41563]

Leave a message and let us know what you liked about the episode!Survivor's guilt is a common and not often talked about emotional experience after cancer. Dr. Leah Sherman sits down with returning guest Natasha Ewa, licensed clinical social worker and founder of I Thrive Therapy and Wellness, for an honest conversation about what survivor's guilt actually looks like, why body image after cancer is so personal, and what healing can feel like on the other side.The conversation widens to cover grief over pre-cancer identity, hypervigilance, reconstruction decisions, and Natasha's documentation of her own DIEP flap experience and complications.Whether you're navigating survivorship yourself or supporting someone who is, this one meets you where you are.Visit the I Thrive Therapy and Wellness websiteFollow Natasha on InstagramSupport the showBecome a member of The Cancer Pod Community! Gain access to live Q&As, exclusive content, and so much more! Join us today on Buy Me a Coffee or on Patreon!Check out our website! Looking for more information? We have blogs, merch, and all of our episodes listed by season and category. Shop our favorite reads! We've joined with Bookshop.org to offer some of our fave books!Buy our merch! Whether it's a cozy hoody or a handy water bottle, we have something for everybody.Have a comment or suggestion? Email us at info (at) thecancerpod (dot) com Follow us wherever you browse. We're always @TheCancerPod:InstagramBlueskyFacebookLinkedInYouTubeTHANK YOU!!

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. David Oh discusses immunotherapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41562]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. David Oh discusses immunotherapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41562]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. David Oh discusses immunotherapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41562]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Stacey Kenfield, ScD, discusses diet and exercise. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41555]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Arpita Desai discusses metastatic hormone sensitive prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41560]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Will Chen discusses PET-directed radiation for Oligometastatic Disease. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41559]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Arpita Desai discusses metastatic hormone sensitive prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41560]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Will Chen discusses PET-directed radiation for Oligometastatic Disease. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41559]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Stacey Kenfield, ScD, discusses diet and exercise. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41555]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Will Chen discusses PET-directed radiation for Oligometastatic Disease. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41559]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Stacey Kenfield, ScD, discusses diet and exercise. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41555]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Arpita Desai discusses metastatic hormone sensitive prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41560]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Ivan de Kouchkovsky discusses radioligand therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41561]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Ivan de Kouchkovsky discusses radioligand therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41561]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Ivan de Kouchkovsky discusses radioligand therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41561]

Men's Health Awareness Month | Strength Through Awareness, Connection & CareJune is Men's Health Awareness Month, a time to bring attention to the physical, emotional, and social aspects of men's well-being.In this episode of Mondays with Bev & Paul, we explore what men's health really means beyond diagnoses and disease. Why do so many men delay seeking help? How does chronic stress affect health? What role do connection, community, and touch play in overall wellness?We'll discuss common challenges facing men today, including stress, isolation, healthy aging, prevention, and the importance of paying attention to our bodies before problems become crises.We'll also highlight one of the most common health concerns for men—prostate health. Throughout June, we are sharing our recorded workshop on Prostate Cancer and Prostate Health, along with a free downloadable workbook to help educate and empower individuals and families.Topics include:• Men's physical, emotional, and mental health• The hidden effects of stress• Why connection matters• Prevention and self-care• Prostate health awareness• Bio-Touch as a simple wellness practiceDownload the free workbook and watch the prostate health workshop through the links provided below.Health begins with awareness. Awareness begins with paying attention.#MensHealthMonth #MensHealth #ProstateHealth #HealthyAging #StressReduction #BioTouch #MondaysWithBevAndPaul #Wellness #HealthAwareness

Mary Ellen Taplin joins us on the heels of her ASCO 2026 Plenary presentation with this exciting phase 3 data certain to generate discussion about the landscape of high risk prostate cancer.

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Julian Hong discusses radiation therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41551]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Julian Hong discusses radiation therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41551]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Julian Hong discusses radiation therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41551]

Sherí Barros, a seasoned marketing and brand executive who currently serves as the Chief Marketing and Communications Officer at ZERO Prostate Cancer.She joined the executive team in October 2024, bringing an extensive background in "purpose-driven" marketing and sports brand partnerships.Professional BackgroundSherí has over 20 years of experience across the nonprofit and for-profit sectors, with a particular specialty in engaging male audiences through high-visibility sports and community brands.ZERO Prostate Cancer (2024–Present): As CMCO, she leads the organization's national marketing, communications, and brand-amplification strategies. Her focus is on the "mission-first" strategy to reduce late-stage diagnoses and address health disparities in the prostate cancer community.American Cancer Society: Before joining ZERO, she was the VP of Sports Brand Partnerships.

As part of the 2026 UCSF Patient Conference on Prostate Cancer, the UCSF Patient Services Committee and California Prostate Cancer Coalition present a panel discussion on resources. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41554]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Peter Carroll discusses biochemical recurrence. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41556]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Samuel Washington discusses active surveillance of prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41549]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, the UCSF Patient Services Committee and California Prostate Cancer Coalition present a panel discussion on resources. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41554]

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Samuel Washington discusses active surveillance of prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41549]

If Part 1 was about the field of sexual medicine, Part 2 is about the marriage at the center of it. Dr. Jenni Skyler and Daniel Lebowitz return to their conversation with Dr. Irwin and Sue Goldstein, and this time, the questions get more personal. How do you stay married for fifty years? What does great sex actually look like across the decades? And what happens when a woman who has spent her career in sexual medicine starts experiencing low desire herself? Sue Goldstein opens up about her own journey through peri-menopause and the slow erosion of her libido- what she calls "duty sex", and the medications that brought not just her sex drive back, but a playfulness in her marriage she hadn't realized had gone missing. She walks listeners through her menopause toolbox of five treatments, explains why she's "76 and feels like she's in her 50s", and dismantles the lingering fears from the Women's Health Initiative that have kept generations of women in what she calls hormone prison. Dr. Irwin shares his own daily protocols for sexual health, why he believes most older men are leaving capacity on the table, and the surprising data from their own clinic- that more than half the Vyleesi prescriptions they write are off-label for men. They explore why dopamine is dopamine, regardless of gender. The reality of persistent genital arousal disorder. And a remarkable story of a teenage horseback rider whose chronic arousal turned out to be a herniated disc. This episode is full of practical wisdom, clinical innovation, and one of the most real conversations about long-term love you'll hear all year. The Goldsteins' secret to fifty years of marriage? Best friends, good sex, and the willingness to keep trying new things — including a chocolate sauce on the day before you change the sheets. Irwin Goldstein, MD, IF (he/him/his). Director, San Diego Sexual Medicine 5555 Reservoir Drive, Suite 300, San Diego, CA 92120, Director, Sexual Medicine, UC San Diego Health East Campus, San Diego, CA. Clinical Professor of Urology, University of California at San Diego. Voluntary Clinical Professor of Obstetrics, Gynecology and Reproductive Services Past President, International Society for the Study of Women’s Sexual Health. Past President, Sexual Medicine Society of North America. Editor Emeritus, Sexual Medicine Reviews, The Journal of Sexual Medicine, International Journal of Impotence Research. Phone: 619 265-8865 - Mobile: 619 987-7432. Email: dr.irwingoldstein@gmail.com. http://www.sandiegosexualmedicine.com. Like us on Facebook: https://www.facebook.com/SDSexMed. X: http://twitter.com/SDSexualMedSee omnystudio.com/listener for privacy information.

AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast CME Available: https://cme.auanet.org/URL/FOCUS262ONL LEARNING OBJECTIVES: After participating in this CME activity, participants will be able to: 1. Critically appraise recent developments in imaging biomarkers and molecular diagnostics (e.g., genomic risk scores, liquid biopsy) and discuss how they complement MRI and PSMA PET in prostate cancer care. 2. Determine the optimal clinical scenarios (diagnostic, staging, recurrence, surveillance) in which PSMA PET/CT or PET/MRI adds value beyond conventional imaging. 3. Recognize potential pitfalls in PSMA PET interpretation — including false positives, false negatives, non–PSMA-expressing disease, and technical artifacts — and implement strategies to mitigate them. 4. Synthesize biomarker, MRI, and PSMA PET findings into a personalized management plan, including guiding biopsy, focal therapy, salvage therapy, or systemic treatments. 5. Select appropriate patients with radiorecurrent or organ-confined prostate cancer for advanced imaging and guide re-treatment decisions (e.g., salvage therapy, targeted radiotherapy). ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Blue Earth Diagnostics, Inc. Lantheus Medical Imaging

As part of the 2026 UCSF Patient Conference on Prostate Cancer, Dr. Carissa Chu discusses surgery for prostate cancer. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 41550]

Smarter treatment paths often begin with asking better questions about what truly works and what simply sounds promising.In this episode, Dr. Stephen Petteruti explains why repurposed drugs are gaining attention in prostate cancer care. He challenges conventional therapies that often offer limited survival benefit despite significant side effects, and highlights how publication bias and interpretation of data can shape treatment narratives. Dr. Stephen outlines how repurposed drugs are selected. Rather than relying on a single solution, he emphasizes synergy: combining therapies like sirolimus and select statins to target cancer pathways while supporting overall health.  If you value longevity and informed decision-making, take a moment to rethink your options. Tune in to the full episode of Repurposed Drugs for Prostate Cancer: What Your Oncologist Will Never Tell You.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.Learn more: https://www.drstephenpetteruti.com/ Learn more: https://www.intellectualmedicine.com/ Connect with Dr. Petteruti on:⁠Instagram: ⁠https://www.instagram.com/dr.stephenpetteruti/⁠ Facebook: ⁠https://www.facebook.com/dr.stephenpetteruti⁠ Subscribe to Intellectual Medicine on:Apple Podcast: https://tinyurl.com/DrPetterutiApplePodcast Spotify: https://tinyurl.com/DrPetterutiSpotifyPodcast Disclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

Guest: Dr Paul Kelly, Medical Director of the UPMC Cancer Network in Ireland

This session features expert Michael Morris discussing radioligand therapy, adaptive dosing, retreatment strategies, and the latest insights in prostate cancer treatment. Gain a deep understanding of current practices, challenges, and future directions in radiopharmaceuticals.